KerenRTremontKLuanXCnaanA. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F317-F322.
2.
IpSChungMKuligJ; American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114:e130-e153.
3.
BrooksJCFisher-OwensSAWuYWStraussDJNewmanTB. Evidence suggests there was not a “resurgence” of kernicterus in the 1990s. Pediatrics. In press.
4.
SgroM.Kernicterus, January 2007 to December, 2008. CPSP Canadian Paediatroc Surveillance Program. Ottawa, Ontario, Canada: Public Health Agency of Canada; 2009: 41-43.
5.
SgroMCampbellDShahV. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175:587-590.
6.
ManningDToddPMaxwellMPlattM. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed. 2007;92:342-346.
7.
BjerreJVPetersenJREbbesenF. Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr. 2008;97:1030-1034.
8.
BjerreJVEbbesenF. Incidence of kernicterus in newborn infants in Denmark [in Danish]. Ugeskr Laeger. 2006;168: 686-691.
9.
BurkeBLRobbinsJMBirdTMHobbsCANesmithCTilfordJM. Trends in hospitalizations for neonatal jaundice and kernicterus in the United States, 1988-2005. Pediatrics. Feb2009;123(2):524-532.
10.
NairPAAl KhusaibySM. Kernicterus and G6PD deficiency—a case series from Oman. J Trop Pediatr. 2003;49:74-77.
11.
YeungCY. Kernicterus in term infants. Aust Paediatr J. 1985;21:273-274.
12.
OwaJAOgunlesiTA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr. 2009;5:51-55.
13.
van de BorMvan Zeben-van der AaTMVerloove-VanhorickSPBrandRRuysJH. Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics. 1989;83:915-920.
14.
van de BorMEns-DokkumMSchreuderAMVeenSBrandRVerloove-VanhorickSP. Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics. 1992;89:359-364.
15.
OhWTysonJEFanaroffAA. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics. 2003;112: 773-779.
16.
SanpavatS. Exchange transfusion and its morbidity in ten-year period at King Chulalongkorn Hospital. J Med Assoc Thai. 2005;88:588-592.
17.
PatraKStorfer-IsserASinerBMooreJHackM. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144:626-631.
18.
JacksonJ. Adverse events associated with exchange transfusion in healthy and ill newborn. Pediatrics. 1997;99:e7.
19.
KeenanWJNovakKKSutherlandJMBrylaDAFetterlyKL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(2 Pt 2):417-421.
20.
AspbergSDahlquistGKahanTKallenB. Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma. Pediatr Allergy Immunol. 2010;21(4 Pt 2):e733-e739.
21.
AspbergSDahlquistGKahanTKallenB. Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?Pediatr Allergy Immunol. 2007;18:313-319.
22.
MaiselsMJMcDonaghAF. Phototherapy for neonatal jaundice. N Engl J Med. 2008;358:920-928.
23.
DahlquistGKallenB. Indications that phototherapy is a risk factor for insulin-dependent diabetes. Diabetes Care. 2003;26:247-248.
24.
BurgosAESchmittSKStevensonDKPhibbsCS. Readmission for neonatal jaundice in California, 1991-2000: trends and implications. Pediatrics. 2008;121: e864-e869.
25.
SeidmanDSPazIArmonYErgazZStevensonDKGaleR. Effect of publication of the “Practice parameter for the management of hyperbilirubinemia” on treatment of neonatal jaundice. Acta Paediatr. 2001;90:292-295.
26.
SteinerLABizzarroMJEhrenkranzRAGallagherPG. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics. 2007;120:27-32.
27.
MaiselsM. Is exchange transfusion for hyperbilirubinemia in danger of becoming extinct? [Abstract]. Pediatr Res. 1999;45:210A.
28.
RennieJMSehgalADeAKendallGSColeTJ. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed. 2009;94:F323-327.
29.
PetrovaAMehtaRBirchwoodGOstfeldBHegyiT. Management of neonatal hyperbilirubinemia: pediatricians’ practices and educational needs. BMC Pediatr. 2006;6:6.
30.
GartnerL. Practice patterns in neonatal hyperbilirubinemia. Pediatrics. 1998;101:25-31.
31.
HansenT. Therapeutic approaches to neonatal jaundice: an international survey. Clin Pediatr (Phila). 1996;35:309-316.
32.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
33.
RennieJBurman-RoySMurphyMS; Guideline Development Group. Neonatal jaundice: summary of NICE guidance. BMJ. 2010;340:c2409.
34.
NewmanTBKohnMA. Evidence-Based Diagnosis. New York, NY: Cambridge University Press; 2009.
35.
EddyD. Common Screening Tests. Philadelphia, PA: American College of Physicians; 1991.
36.
KerenRLuanXFriedmanSSaddlemireSCnaanABhutaniVK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121:e170-e179.
37.
KramerLI. Advancement of dermal icterus in the jaundiced newborn. Am J Dis Child. 1969;118:454-458.
38.
RiskinATamirAKugelmanAHemoMBaderD. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia?J Pediatr. 2008;152:782-787.
39.
RiskinAKuglmanAAbend-WeingerMGreenMHemoMBaderD. In the eye of the beholder: how accurate is clinical estimation of jaundice in newborns?Acta Paediatr. 2003;92:574-576.
40.
MoyerVAAhnCSneedS. Accuracy of clinical judgment in neonatal jaundice. Arch Pediatr Adolesc Med. 2000;154: 391-394.
41.
Madlon-KayDJ. Recognition of the presence and severity of newborn jaundice by parents, nurses, physicians, and icterometer. Pediatrics. 1997;100:E3.
42.
EbbesenF. The relationship between the cephalo-pedal progress of clinical icterus and the serum bilirubin concentration in newborn infants without blood type sensitization. Acta Obstet Gynecol Scand. 1975;54:329-332.
43.
MaiselsMJBhutaniVKBogenDNewmanTBStarkARWatchkoJF. Management of hyperbilirubinemia in the newborn infant ≥35 weeks’ gestation—an update with clarifications. Pediatrics. 2009;124:1193-1198.
44.
NewmanTB. Universal bilirubin screening, guidelines, and evidence. Pediatrics. 2009;124:1199-1202.
45.
TrikalinosTChungMLauJIpS. Systematic review of screening for bilirubin encephalopathy in neonates. Pediatrics. 2009;124:1162-1171.
46.
KuzniewiczMWEscobarGJNewmanTB. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Pediatrics. 2009;124: 1031-1039.
47.
BhutaniVKJohnsonLSivieriEM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14.
48.
MaiselsMJNewmanTB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics. 1999;103:493-495.
49.
MaiselsMJKringE. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of > or = 35 weeks’ gestation. Pediatrics. 2006;117: 1169-1173.
50.
NewmanTBLiljestrandPEscobarGJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159:113-119.
51.
KerenRBhutaniVKLuanXNihtianovaSCnaanASchwartzJS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90:415-421.
52.
BhutaniVKJohnsonLH. Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. Clin Chem. 2004;50:477-480.
53.
De LucaDJacksonGLTridenteACarnielliVPEngleWD. Transcutaneous bilirubin nomograms: a systematic review of population differences and analysis of bilirubin kinetics. Arch Pediatr Adolesc Med. 2009;163: 1054-1059.
54.
MaiselsMJ. Jaundice. In: MacDonaldMSeshiaMMullettM, eds. Neonatology: Pathophysiology and Management of the Newborn. 6th ed.Philadelphia, PA: JB Lippincott; 2005:768-846.
55.
NewmanTBXiongBGonzalesVMEscobarGJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-1147.
56.
MaiselsMJGiffordKAntleCELeibGR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics. 1988;81:505-511
57.
GaleRSeidmanDSDollbergSStevensonDK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10:82-86.
58.
OsbornLMLenarskyCOakesRCReiffMI. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility. Pediatrics. 1984;74: 371-374.
59.
LinnSSchoenbaumSCMonsonRRRosnerBStubblefieldPGRyanKJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics. 1985;75:770-774.
60.
MaiselsMJDeridderJMKringEABalasubramaniamM. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol. 2009;29: 612-617.
61.
EggertLDWiedmeierSEWilsonJChristensenRD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics. 2006;117:e855-e862.
62.
MahMPClarkSLAkhigbeE. Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening. Pediatrics. 2010;125:e1143-e1148.
63.
MaiselsMJ. Jaundice. In: SinclairJCBrackenMB. Effective Care of the Newborn Infant. Oxford, UK: Oxford University Press; 1992:507-561.
64.
ChangPFLinYCLiuKYehSJNiYH. Prolonged unconjugated hyperbiliriubinemia in breast-fed male infants with a mutation of uridine diphosphate-glucuronosyl transferase. J Pediatr. 2009;155:860-863.
65.
EngleWATomashekKMWallmanC. “Late-preterm” infants: a population at risk. Pediatrics. 2007;120:1390-1401.
66.
BertiniGDaniCTronchinMRubaltelliFF. Is breastfeeding really favoring early neonatal jaundice?Pediatrics. 2001;107:E41.
67.
WiedemannMKontushAFinckhBHellwegeHHKohlschütterA. Neonatal blood plasma is less susceptible to oxidation than adult plasma owing to its higher content of bilirubin and lower content of oxidizable fatty acids. Pediatr Res. 2003;53:843-849.
68.
KuzniewiczMWEscobarGJWiSLiljestrandPMcCullochCNewmanTB. Risk factors for severe hyperbilirubinemia among infants with borderline bilirubin levels: a nested case-control study. J Pediatr. 2008;153:234-240.
69.
GourleyGRKreamerBArendR. The effect of diet on feces and jaundice during the first 3 weeks of life. Gastroenterology. 1992;103:660-667.
70.
LonghurstCTurnerSBurgosAE. Development of a Web-based decision support tool to increase use of neonatal hyperbilirubinemia guidelines. Jt Comm J Qual Patient Saf. 2009;35:256-262.
71.
LonghurstCTurnerSBurgosAE. BiliTool. 2004. http://www.bilitool.org. Accessed November 23, 2010.
72.
AgulnikARyuminaIIBurgosAE. Hyperbilirubinemia guideline adherence in Russia illustrates universal challenges. Eur J Pediatr. 2009;168:1175-1180.
73.
BhutaniVKJohnsonL. Synopsis report from the pilot USA Kernicterus Registry. J Perinatol. 2009;29(Suppl 1):S4-S7.
74.
MallouhAAImseehGAbu-OsbaYKHamdanJA. Screening for glucose-6-phosphate dehydrogenase deficiency can prevent severe neonatal jaundice. Ann Trop Paediatr. 1992;12:391-395.
75.
AtkinsonLEscobarGTakayamaJNewmanT. Phototherapy use in jaundiced newborns in a large managed care organization: do physicians adhere to the guideline?Pediatrics. 2003;111:e555-e561.
LoSFDoumasBTAshwoodER. Bilirubin proficiency testing using specimens containing unconjugated bilirubin and human serum: results of a College of American Pathologists study. Arch Pathol Lab Med. 2004;128:1219-1223.
79.
LoSFDoumasBTAshwoodER. Performance of bilirubin determinations in US laboratories—revisited. Clin Chem. 2004;50:190-194.
80.
LoSFJendrzejczakBDoumasBT. Total or neonatal bilirubin assays in the Vitros 5,1 FS: hemoglobin interference, hemolysis, icterus index. Clin Chem. 2007;53:799-800.
81.
BhutaniVKGourleyGRAdlerSKreamerBDalinCJohnsonLH. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics. 2000;106:E17.
82.
MaiselsMJOstreaEMJrCepedaE. Evaluation of the the Minolta Model 103 transcutaneous bilirubinometer. Pediatr Res. 2002;51:341A.
83.
JanjindamaiWTansantiwongT. Accuracy of transcutaneous bilirubinometer estimates using BiliCheck in Thai neonates. J Med Assoc Thai. 2005;88:187-190.
84.
EngleWDJacksonGLSendelbachDManningDFrawleyWH. Assessment of a transcutaneous device in the evaluation of neonatal hyperbilirubinemia in a primarily Hispanic population. Pediatrics. 2002;110(1 Pt 1):61-67.
85.
MaiselsMJOstreaEMJrTouchS. Evaluation of a new transcutaneous bilirubinometer. Pediatrics. 2004;113: 1628-1635.
86.
PolandRLHartenbergerCMcHenryHHsiA. Comparison of skin sites for estimating serum total bilirubin in in-patients and out-patients: chest is superior to brow. J Perinatol. 2004;24:541-543.